Bal, Susan http://orcid.org/0000-0002-8206-8919
Malek, Ehsan
Kansagra, Ankit http://orcid.org/0000-0001-6901-0782
Usmani, Saad Z. http://orcid.org/0000-0002-5484-8731
Vij, Ravi
Godby, Kelly N.
Cornell, Robert F.
Kang, Yubin
Umyarova, Elvira
Giri, Smith
Chhabra, Saurabh http://orcid.org/0000-0001-9117-8696
Liedtke, Michaela
Callander, Natalie S. http://orcid.org/0000-0002-6975-1086
Hari, Parameswaran http://orcid.org/0000-0002-8800-297X
Kumar, Shaji http://orcid.org/0000-0001-5392-9284
Costa, Luciano J.
Article History
Received: 11 October 2021
Revised: 28 October 2021
Accepted: 4 November 2021
First Online: 20 November 2021
Competing interests
: EhM: Consultancy and Speakers Bureau (Takeda, Celgene, Amgen, Janssen); ML: Consultancy (Amgen/Onyx), Honoraria (Amgen/Onyx, Pfizer, Prothena, Takeda), Research Funding (Amgen/Onyx, BlueBirdBio, Celgene, Genentech/Roche, Gilead, Pfizer, Prothena, Takeda), Membership on an entity’s Board of Directors or advisory committees (Caelum, Pfizer, Prothena, Takeda); PH: Consultancy and Research Funding (Amgen, Celgene), Honoraria (Celgene); RV: Honoraria (Celgene, Bristol Myers Squibb, Takeda, Amgen, Janssen, Karyopharma, Jazz), Research Funding (Celgene, Bristol Myers Squibb, Takeda); SU: Consultancy (Abbvie, Amgen, Celgene, Genmab, Merck, MundiPharma, Seattle Genetics), Research Funding (Amgen, BMS, Celgene, Janssen, Merck, Pharmacyclics, Takeda), Membership on an entity’s Board of Directors or advisory committees (Sanofi); ShK: Consultancy (AbbVie, Celgene, Janssen, Kite Pharma, Merck, Takeda); LC: Honoraria (Amgen, Celgene, AbbVie), Research Funding (Amgen, Celgene, Janssen). SB has received research funding from Amyloid Foundation. SG is supported in part by the Walter B. Frommeyer Fellowship in Investigative Medicine at the University of Alabama at Birmingham and reports receiving research funding from Carevive Systems and Pack Health. SC: Research Funding: Amgen, Janssen, Sanofi; Honorarium: Glaxo Smith Kline. Other authors do not have any conflicts of interest to disclose.